Scrip Code / Symbol: 543748 (BSE), AARTIPHARM (NSE)
Aarti Pharmalabs Limited has granted 850 (Eight Hundred and Fifty) stock options to certain eligible employees of the Company under the 'APL Performance Stock Option Plan- 2023' (PSOP 2023).
The grant was approved by the Nomination and Remuneration Committee of the Board of Directors at its meeting held on Wednesday, October 28, 2026.
Key Details:
- Number of Options Granted: 850
- Exercise Price: ₹5 (Rupees Five Only) per option
- Plan Name: APL Performance Stock Option Plan- 2023 (PSOP 2023)
- Regulatory Compliance: The grant is subject to the provisions of the Securities and Exchange Board of India (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
The letter was digitally signed by Jeevan Bhargav Mondkar, Company Secretary and Legal Head (ICSI Membership No. A22565), on October 28, 2026 at 19:44:29 IST.
Additional Announcements
No additional corporate updates were included in this filing.